Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity

Imatinib mesylate is a small-molecule tyrosine kinase inhibitor (TKi) designed to target c-ABL and BCR-ABL, approved for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors. Adverse cutaneous reactions induced by imatinib are frequent, generally moderate, and dose-dependent...

Descripción completa

Detalles Bibliográficos
Autores principales: Musolino, Caterina, Allegra, Alessandro, Mannucci, Carmen, Russo, Sabina, Alonci, Andrea, Maisano, Valerio, Calapai, Gioacchino, Gangemi, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451486/
https://www.ncbi.nlm.nih.gov/pubmed/26316486
http://dx.doi.org/10.4274/tjh.2014.0021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451486/
https://www.ncbi.nlm.nih.gov/pubmed/26316486
http://dx.doi.org/10.4274/tjh.2014.0021

Ejemplares similares